86 related articles for article (PubMed ID: 13753296)
41. [Clinical-experimental research on Formylalbucid].
ROSE W; JAROSS W
Chemotherapia (Basel); 1961; 2():65-79. PubMed ID: 13743299
[No Abstract] [Full Text] [Related]
42. [Experimental and clinical experiences with a proved trisulfonamide in a new depot from].
KROSCHEL H
Dtsch Med J; 1960 Nov; 11():563-7. PubMed ID: 13754528
[No Abstract] [Full Text] [Related]
43. The sensitivity of aspergilli to sulphonamides.
VIRTANEN S
Acta Pathol Microbiol Scand Suppl; 1962; Suppl 154():268-9. PubMed ID: 13926199
[No Abstract] [Full Text] [Related]
44. Potentiation in combinations of three biochemically related antimetabolites.
ELION GB; SINGER S; HITCHINGS GH
Antibiot Chemother (Northfield); 1960 Sep; 9():556-64. PubMed ID: 13819933
[No Abstract] [Full Text] [Related]
45. The enigma of secretory otitis media.
Brockman SJ
Trans Am Acad Ophthalmol Otolaryngol; 1972; 76(5):1296-304. PubMed ID: 4666580
[No Abstract] [Full Text] [Related]
46. [Experiments on the sulfonamide-sensitivity of 405 strains of bacteria isolated in the years 1958 and 1959].
CETIN ET; ANG O; ONOZ E; TORECI K
Tip Fak Mecm; 1960; 23():411-30. PubMed ID: 13692074
[No Abstract] [Full Text] [Related]
47. [On the problem of the therapy of acute otitis and mastoiditis].
Novotny O
Monatsschr Ohrenheilkd Laryngorhinol; 1968; 102(8):460-7. PubMed ID: 5726597
[No Abstract] [Full Text] [Related]
48. [On the knowledge of and activity of pyrazolosulfonamides].
GUARNERI M
Boll Chim Farm; 1960 May; 99():259-62. PubMed ID: 13829947
[No Abstract] [Full Text] [Related]
49. [Therapeutic trials in experimental toxoplasmosis].
PALENCIA L; TORROELLA J; VARELA G
Rev Inst Salubr Enferm Trop; 1959 Mar; 19():7-10. PubMed ID: 14429899
[No Abstract] [Full Text] [Related]
50. [Pharmacological data on N-(cyclo-hexylcarbamoyl)-p-chlorobenzenesulfonamides].
TORDOS L; ERDEY I
Farmakol Toksikol; 1962; 25():93-8. PubMed ID: 13921923
[No Abstract] [Full Text] [Related]
51. On a defensive reaction of the plant cell; a contribution to the comparative pharmacology of sulphonamides.
RISCHKOV VL
Dokl Akad Nauk Soiuza Sov Sotsialisticheskikh Resp; 1945; 47(7):520-2. PubMed ID: 21026708
[No Abstract] [Full Text] [Related]
52. [Neuro-otological complications of middle ear infection; the importance of early recognition].
Van Buchem FL; Peeters MF
Ned Tijdschr Geneeskd; 1996 Oct; 140(40):2009. PubMed ID: 8965934
[No Abstract] [Full Text] [Related]
53. Acute otitis media. Evidence base on managing acute otitis media had inaccuracies.
Sandhu G; Frosh A; Wright A
BMJ; 2000 Jan; 320(7228):182; author reply 183. PubMed ID: 10681133
[No Abstract] [Full Text] [Related]
54. [Effect of 3-(p-aminobenzenesulfonamido)-2-phenylpyrazole on cholesterol metabolism].
PETROVIC BS
Srp Arh Celok Lek; 1961 Sep; 89():959-75. PubMed ID: 14485956
[No Abstract] [Full Text] [Related]
55. [Preliminary report on the effect of orisul on blood cholesterol].
PETROVIC BS
Srp Arh Celok Lek; 1959; 87():659-60. PubMed ID: 14432378
[No Abstract] [Full Text] [Related]
56. [Comparison of a sulfonamide-sensitive and a sulfonamide-resistant strain of Escherichia coli: study of the minimum requirement of sulfur and nitrogen].
PIERFITTE M
C R Seances Soc Biol Fil; 1960; 154():665-8. PubMed ID: 13735552
[No Abstract] [Full Text] [Related]
57. Otitis media in general practice.
Pearse PA; Bridges-Webb C
Med J Aust; 1993 Apr; 158(8):542-4. PubMed ID: 8487719
[No Abstract] [Full Text] [Related]
58. [Conservative therapy of chronic suppurative otitis media].
IANKOV G
Khirurgiia (Sofiia); 1957; 10(1):5-18. PubMed ID: 13464010
[No Abstract] [Full Text] [Related]
59. Clinical approach to treatment of otitis media.
Jordan MJ
Otolaryngol Clin North Am; 1991 Aug; 24(4):901-4. PubMed ID: 1870881
[TBL] [Abstract][Full Text] [Related]
60. Pathogenesis and diagnosis of otitis media with ANCA-associated vasculitis.
Yoshida N; Iino Y
Allergol Int; 2014 Dec; 63(4):523-32. PubMed ID: 25339433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
